Yael Thollot
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effectiveness of the Local Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey of Healthcare Professionals and Vaccinees.
Journal: Pharmacoepidemiology and drug safety
Published: May 13, 2025
Risk assessment and mitigation evaluation of future yellow fever outbreaks under different climate scenarios: Insight from a case study of Brazil.
Journal: PLoS neglected tropical diseases
Published: February 27, 2025
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial.
Journal: Human vaccines & immunotherapeutics
Published: April 21, 2022
Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra®) in the Republic of Korea, 2014-2019.
Journal: Infectious diseases and therapy
Published: October 29, 2020
Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric.
Journal: Expert review of vaccines
Published: February 27, 2019
Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months.
Journal: Indian pediatrics
Published: February 13, 2019
Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam.
Journal: Pharmacoepidemiology and drug safety
Published: November 20, 2018
Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study.
Journal: Human vaccines & immunotherapeutics
Published: November 08, 2018
Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015.
Journal: Infectious diseases and therapy
Published: November 06, 2018
Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial.
Journal: Human vaccines & immunotherapeutics
Published: February 23, 2018
Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina.
Journal: Human vaccines & immunotherapeutics
Published: September 22, 2017
Last Updated: 09/26/2026